Close Menu

In PLoS ONE this week, University of Washington, Seattle, researchers report their identification of novel prognostic molecular features in acute myeloid leukemia, derived from their cross-study analyses of 25 gene expression profiling studies. One third of the 4,918 reported genes were replicated in more than one study, but only 9.6 percent of those repeated were associated with AML prognostics, the authors report.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.